Pulmotil G40 Premix for medicated feeding stuff

Negara: Irlandia

Bahasa: Inggris

Sumber: HPRA (Health Products Regulatory Authority)

Bahan aktif:

Tilmicosin

Tersedia dari:

Elanco Animal Health, Eli Lilly and Company Limited

Kode ATC:

QJ01FA91

INN (Nama Internasional):

Tilmicosin

Dosis:

40 gram(s)/kilogram(s)

Bentuk farmasi:

Premix for medicated feeding stuff

Jenis Resep:

POM: Prescription Only Medicine as defined in relevant national legislation

Kelompok Terapi:

Porcine, Rabbits

Area terapi:

tilmicosin

Indikasi Terapi:

Antibacterial

Status otorisasi:

Authorised

Tanggal Otorisasi:

1997-01-27

Karakteristik produk

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Pulmotil G40 Premix for medicated feedingstuff
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCE:
Tilmicosin (as phosphate) 40 g/kg
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Premix for medicated feedingstuff.
A yellowish tan to reddish tan free flowing granular material.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Pigs and rabbits
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Pigs: Prevention and treatment of respiratory disease caused by_
Actinobacillus pleuropneumoniae, Mycoplasma_
_hyopneumoniae, Pasteurella multocida_ and other organisms sensitive
to tilmicosin.
Rabbits: Prevention and treatment of respiratory disease caused by_
Pasteurella multocida_ and_ Bordetella_
_bronchiseptica,_ susceptible to tilmicosin.
4.3 CONTRAINDICATIONS
Horses or other E_quidae_, must not be allowed access to feeds
containing tilmicosin. Horses fed with tilmicosin medicated
feeds may present signs of toxicity with lethargy, anorexia, reduction
of feed consumption, loose stools, colic, distension of
the abdomen and death.
Do not use in case of hypersensitivity to tilmicosin or to any of the
excipients.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Under practical conditions, the management of respiratory disease
outbreaks recognises that acutely ill animals are
inappetant and require parenteral therapy.
I
R
I
S
H
M
E
D
I
C
I
N
E
S
B
O
A
R
D
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_0_
_4_
_/_
_1_
_1_
_/_
_2_
_0_
_1_
_3_
_C_
_R_
_N_
_ _